Рынок липидов POCT в Азиатско-Тихоокеанском регионе по типу (инструменты, расходные материалы и наборы), применению (гиперлипидемия, гипертриглицеридемия, гиперлипопротеинемия, семейная гиперхолестеринемия, болезнь Танжера и другие), режиму (тестирование по рецепту, тестирование без рецепта), бренду (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek и другим), платформе (анализы с латеральным потоком (иммунохроматографические тесты), молекулярной диагностике, иммуноанализах, тест-полосках, микрофлюидике), конечному пользователю (больницам, профессиональным диагностическим центрам, домашнему уходу, исследовательским лабораториям, другим конечным пользователям), каналу сбыта (прямой тендер, розничные продажи), стране (Япония, Китай, Южная Корея, Индия, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Тенденции и прогнозы развития отрасли на Филиппинах и в других странах Азиатско-Тихоокеанского региона до 2028 года
Анализ рынка и аналитика: рынок липидов POCT в Азиатско-Тихоокеанском регионе
Ожидается, что рынок липидов POCT будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок будет расти со среднегодовым темпом роста 6,7% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 222,28 млн долларов США к 2028 году. Рост числа хронических инфекций привел к тому, что люди стали выбирать наборы и продукты для тестирования в месте оказания помощи, и, следовательно, это будет способствовать росту рынка липидов POCT.
POCT характеризуется как тестирование, которое может быть проведено близко к пациенту, где медицинское решение может быть принято немедленно, включая результаты и мониторинг . POCT липидов также называется тестированием липидов с пациентом и позволяет врачам точно измерять результаты диагностики лабораторного качества в реальном времени менее чем за несколько минут, а не часов.
Новые биотехнологические достижения создают огромные стимулирующие факторы и стимулируют рост рынка липидных POCT. Высокая стоимость продуктов может сдерживать рост рынка липидных POCT. Ожидается, что растущие расходы на здравоохранение станут возможностью для роста рынка липидных POCT. Отсутствие согласованности с результатами тестов, полученными из лабораторий, создает огромную проблему для рынка липидных POCT.
Отчет о рынке липидных POCT содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и сценарий рынка липидных POCT, свяжитесь с Data Bridge Market Research для получения аналитического обзора, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Объем и размер рынка липидов POCT
The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
- On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
- On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
- On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
- On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
- On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
- On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
Asia-Pacific Lipid POCT Market Country Level Analysis
Asia-Pacific lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.
The countries covered in the Asia-Pacific lipid POCT market report are the Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.
China is going to dominate in the Asia-Pacific lipid POCT market because of the increasing diagnosis rate and awareness about the cardiovascular disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market
The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Lipid POCT Market Share Analysis
The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific lipid POCT market.
The major companies covered in the Asia-Pacific lipid POCT market report are Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., PTS Diagnostics, Trinity Biotech, AMD SOLUTIONS, Siemens Healthcare GmbH (a subsidiary of Siemens), TASCOM, General Life Biotechnology Co., Ltd., MICO BIOMED, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, Nova Biomedical, Quest Diagnostics Incorporated, SKYLA CORPORATION among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.
For instance,
- In November 2020, SD Biosensor, INC. announced its partnership with DKSH Korea to develop pharmacy blood sugar business. This will help the company to diversify its market in coming years.
Сотрудничество, совместные предприятия и другие стратегии участников рынка расширяют возможности компании на рынке липидных ПОКТ, что также дает организациям возможность улучшить свое предложение на рынке липидных ПОКТ.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC LIPID POCT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DISTRIBUTION CHANNEL LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 IMPROVING DIAGNOSIS SEEKING RATE
5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS
5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE
5.1.5 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 PRODUCT RECALLS
5.2.2 HIGH COSTS OF PRODUCTS
5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING HEALTHCARE EXPENDITURE
5.3.3 PANDEMIC OUTBREAK OF COVID-19
5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 LACK OF ACCESSIBILITY
6 IMPACT OF COVID-19 ON THE ASIA-PACIFIC LIPID POCT MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19
6.5 CONCLUSION:
1 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE
1.1 OVERVIEW
1.2 INSTRUMENTS
1.2.1 ANALYZERS
1.2.1.1 PORTABLE
1.2.1.2 HANDHELD
1.2.1.3 STANDALONE
1.2.2 METER
1.2.3 BLOOD MONITORING DEVICE
1.2.4 OTHER POC PRODUCTS
1.3 CONSUMABLES AND KITS
1.3.1 CHOLESTEROL TEST KITS
1.3.2 STRIPS
1.3.3 ACCESSORIES
1.3.4 OTHERS
2 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION
2.1 OVERVIEW
2.2 HYPERLIPIDEMIA
2.3 HYPERTRIGLYCERIDEMIA
2.4 HYPERLIPOPROTEINEMIA
2.5 FAMILIAL HYPERCHOLESTEROLEMIA
2.6 TANGIER DISEASE
2.7 OTHERS
3 ASIA-PACIFIC LIPID POCT MARKET, BY MODE
3.1 OVERVIEW
3.2 PRESCRIPTION-BASED TESTING
3.3 OTC-BASED TESTING
4 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND
4.1 OVERVIEW
4.2 ROCHE REFLOTRON
4.3 ROCHE COBAS B 101
4.4 ALERE CHOLESTECH LDX
4.5 ALERE AFINION
4.6 PTS CARDIOCHEK
4.7 OTHERS
5 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM
5.1 OVERVIEW
5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
5.3 MOLECULAR DIAGNOSTICS
5.4 IMMUNOASSAYS
5.5 DIPSTICKS
5.6 MICROFLUIDICS
6 ASIA-PACIFIC LIPID POCT MARKET, BY END USER
6.1 OVERVIEW
6.2 HOSPITALS
6.3 PROFESSIONAL DIAGNOSTIC CENTERS
6.3.1 CLINICAL LABORATORIES
6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS
6.4 HOME CARE
6.5 RESEARCH LABORATORIES
6.6 OTHER END USERS
7 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT TENDERS
7.3 RETAIL SALES
8 ASIA-PACIFIC LIPID POCT MARKET, BY REGION
8.1 ASIA-PACIFIC
8.1.1 JAPAN
8.1.2 CHINA
8.1.3 SOUTH KOREA
8.1.4 INDIA
8.1.5 AUSTRALIA
8.1.6 SINGAPORE
8.1.7 THAILAND
8.1.8 MALAYSIA
8.1.9 INDONESIA
8.1.10 PHILIPPINES
8.1.11 REST OF ASIA-PACIFIC
9 ASIA-PACIFIC LIPID POCT MARKET: COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
10 SWOT ANALYSIS
11 COMPANY PROFILES
11.1 F. HOFFMANN-LA ROCHE LTD
11.1.1 COMPANY SNAPSHOT
11.1.2 REVENUE ANALYSIS
11.1.3 COMPANY SHARE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENT
11.2 ABBOTT
11.2.1 COMPANY SNAPSHOT
11.2.2 REVENUE ANALYSIS
11.2.3 COMPANY SHARE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENT
11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)
11.3.1 COMPANY SNAPSHOT
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 QUEST DIAGNOSTICS INCORPORATED
11.4.1 COMPANY SNAPSHOT
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPMENTS
11.5 A. MENARINI DIAGNOSTICS S.R.L
11.5.1 COMPANY SNAPSHOT
11.5.2 COMPANY SHARE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENT
11.6 ACON LABORATORIES, INC.
11.6.1 COMPANY SNAPSHOT
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENT
11.7 AMD SOLUTIONS
11.7.1 COMPANY SNAPSHOT
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 CALLEGARI SRL
11.8.1 COMPANY SNAPSHOT
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 EUROMEDIX
11.9.1 COMPANY SNAPSHOT
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENT
11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.
11.10.1 COMPANY SNAPSHOT
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 JANT PHARMACAL CORPORATION
11.11.1 COMPANY SNAPSHOT
11.11.2 PRODUCT PORTFOLIO
11.11.3 RECENT DEVELOPMENT
11.12 MICO BIOMED
11.12.1 COMPANY SNAPSHOT
11.12.2 PRODUCT PORTFOLIO
11.12.3 RECENT DEVELOPMENTS
11.13 NOVA BIOMEDICAL
11.13.1 COMPANY SNAPSHOT
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 PRIMA LAB SA
11.14.1 COMPANY SNAPSHOT
11.14.2 PRODUCT PORTFOLIO
11.14.3 RECENT DEVELOPMENTS
11.15 PTS DIAGNOSTICS
11.15.1 COMPANY SNAPSHOT
11.15.2 PRODUCT PORTFOLIO
11.15.3 RECENT DEVELOPMENTS
11.16 SD BIOSENSOR, INC.
11.16.1 COMPANY SNAPSHOT
11.16.2 PRODUCT PORTFOLIO
11.16.3 RECENT DEVELOPMENTS
11.17 SKYLA CORPORATION
11.17.1 COMPANY SNAPSHOT
11.17.2 PRODUCT PORTFOLIO
11.17.3 RECENT DEVELOPMENTS
11.18 TASCOM
11.18.1 COMPANY SNAPSHOT
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENT
11.19 TRINITY BIOTECH
11.19.1 COMPANY SNAPSHOT
11.19.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.2 SAMSUNG MEDISON CO., LTD.
11.20.1 COMPANY SNAPSHOT
11.20.2 PRODUCT PORTFOLIO
11.20.3 RECENT DEVELOPMENT
12 QUESTIONNAIRE
13 RELATED REPORTS
Список таблиц
LIST OF TABLES
TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:
TABLE 1 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)
TABLE 15 ASIA-PACIFIC PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 50 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 JAPAN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 JAPAN INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 JAPAN ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 JAPAN ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 58 JAPAN CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 JAPAN LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 JAPAN LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 61 JAPAN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 62 JAPAN LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 63 JAPAN LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 64 JAPAN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 JAPAN PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 JAPAN LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 67 CHINA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 CHINA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 CHINA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 70 CHINA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 71 CHINA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 CHINA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 CHINA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 74 CHINA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 75 CHINA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 76 CHINA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 77 CHINA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 CHINA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 CHINA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 SOUTH KOREA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 SOUTH KOREA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 SOUTH KOREA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 83 SOUTH KOREA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 84 SOUTH KOREA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 SOUTH KOREA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 SOUTH KOREA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 87 SOUTH KOREA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 88 SOUTH KOREA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 89 SOUTH KOREA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 90 SOUTH KOREA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 SOUTH KOREA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 SOUTH KOREA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 93 INDIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 INDIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 95 INDIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 96 INDIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 97 INDIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 98 INDIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 INDIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 100 INDIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 101 INDIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 102 INDIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 103 INDIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 104 INDIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 INDIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 106 AUSTRALIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 AUSTRALIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 AUSTRALIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 109 AUSTRALIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 110 AUSTRALIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 111 AUSTRALIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 AUSTRALIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 113 AUSTRALIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 114 AUSTRALIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 115 AUSTRALIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 116 AUSTRALIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 117 AUSTRALIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 118 AUSTRALIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 SINGAPORE LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 SINGAPORE INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 SINGAPORE ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 122 SINGAPORE ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 123 SINGAPORE CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 SINGAPORE LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 125 SINGAPORE LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 126 SINGAPORE LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 127 SINGAPORE LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 128 SINGAPORE LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 129 SINGAPORE LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 130 SINGAPORE PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 SINGAPORE LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 132 THAILAND LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 133 THAILAND INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 134 THAILAND ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 135 THAILAND ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 136 THAILAND CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 THAILAND LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 138 THAILAND LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 139 THAILAND LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 140 THAILAND LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 141 THAILAND LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 142 THAILAND LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 143 THAILAND PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 144 THAILAND LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 145 MALAYSIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 146 MALAYSIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 MALAYSIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 148 MALAYSIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 149 MALAYSIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 150 MALAYSIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 151 MALAYSIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 152 MALAYSIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 153 MALAYSIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 154 MALAYSIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 155 MALAYSIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 156 MALAYSIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 157 MALAYSIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 158 INDONESIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 159 INDONESIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 160 INDONESIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 161 INDONESIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 162 INDONESIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 163 INDONESIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 164 INDONESIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 165 INDONESIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 166 INDONESIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 167 INDONESIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 168 INDONESIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 169 INDONESIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 170 INDONESIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 171 PHILIPPINES LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 172 PHILIPPINES INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 173 PHILIPPINES ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 174 PHILIPPINES ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 175 PHILIPPINES CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 176 PHILIPPINES LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 177 PHILIPPINES LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 178 PHILIPPINES LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 179 PHILIPPINES LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 180 PHILIPPINES LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 181 PHILIPPINES LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 182 PHILIPPINES PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 183 PHILIPPINES LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 184 REST OF ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
Список рисунков
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC LIPID POCT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC LIPID POCT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC LIPID POCT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC LIPID POCT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC LIPID POCT MARKET: MULTIVARIATE MODELLING
FIGURE 8 ASIA-PACIFIC LIPID POCT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC LIPID POCT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC LIPID POCT MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE ASIA-PACIFIC LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC LIPID POCT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC LIPID POCT MARKET
FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT
FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016
FIGURE 1 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, 2020
FIGURE 2 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 3 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 4 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 5 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, 2020
FIGURE 6 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 7 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 8 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 9 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, 2020
FIGURE 10 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)
FIGURE 11 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, CAGR (2021-2028)
FIGURE 12 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, LIFELINE CURVE
FIGURE 13 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, 2020
FIGURE 14 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)
FIGURE 15 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)
FIGURE 16 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, LIFELINE CURVE
FIGURE 17 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, 2020
FIGURE 18 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)
FIGURE 19 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)
FIGURE 20 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, 2020
FIGURE 22 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 23 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 24 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 26 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 27 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 28 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC LIPID POCT MARKET: SNAPSHOT (2020)
FIGURE 30 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2020)
FIGURE 31 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 32 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 33 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE (2021-2028)
FIGURE 34 ASIA-PACIFIC LIPID POCT MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
